HYBRID EVENT: You can participate in person at Boston, Massachusetts, USA or Virtually from your home or work.

7th Edition of Global Conference on

Addiction Medicine, Behavioral Health and Psychiatry

October 19-21, 2026 | Boston, Massachusetts, USA

Endocannabinoid System Dysregulation in Addiction

Endocannabinoid System Dysregulation in Addiction

The endocannabinoid system (ECS) is vital in maintaining emotional balance, stress regulation, and reward processing. Chronic substance use disrupts this system, altering the function of cannabinoid receptors and the production of endocannabinoids. For example, excessive cannabis use desensitizes the CB1 receptor, leading to reduced natural reward responses and increased cravings. Similarly, other substances indirectly affect the ECS by impairing its interaction with neurotransmitter systems. This dysregulation contributes to withdrawal symptoms, heightened stress sensitivity, and difficulty sustaining sobriety. Emerging therapies aim to restore ECS function using receptor modulators, dietary changes, and physical activities that promote endocannabinoid balance. Understanding the ECS’s role in addiction provides a promising direction for personalized treatments that target the biological underpinnings of dependency. Such interventions can improve emotional stability, reduce relapse rates, and support long-term recovery.

Tags

Submit your abstract Today

Watsapp